Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Change in Receivables (2016 - 2025)

American Healthcare REIT (AHR) has disclosed Change in Receivables for 10 consecutive years, with $17.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 897.68% year-over-year to $17.2 million, compared with a TTM value of $13.0 million through Dec 2025, down 45.04%, and an annual FY2025 reading of $13.0 million, down 45.04% over the prior year.
  • Change in Receivables was $17.2 million for Q4 2025 at American Healthcare REIT, up from -$17.7 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $32.1 million in Q1 2024 and bottomed at -$17.7 million in Q3 2025.
  • Average Change in Receivables over 5 years is $3.6 million, with a median of $3.1 million recorded in 2023.
  • Peak annual rise in Change in Receivables hit 1497.69% in 2021, while the deepest fall reached 13611.48% in 2021.
  • Year by year, Change in Receivables stood at $1.8 million in 2021, then tumbled by 295.54% to -$3.6 million in 2022, then soared by 509.77% to $14.7 million in 2023, then tumbled by 88.29% to $1.7 million in 2024, then soared by 897.68% to $17.2 million in 2025.
  • Business Quant data shows Change in Receivables for AHR at $17.2 million in Q4 2025, -$17.7 million in Q3 2025, and $3.5 million in Q2 2025.